Utility:
| Higher prevalence of anti-B2GPI-DI antibodies among patients with APS compared with SLE alone; Domain 1 positivity doubles the thrombotic risk compared with patients negative for Domain 1 |
Utility:
| Higher prevalence of anti-B2GPI-DI antibodies among patients with APS compared with SLE alone; Domain 1 positivity doubles the thrombotic risk compared with patients negative for Domain 1 |
Werfen.com. All rights Reserved. Privacy Policy | Cookies Policy | Terms of Service